RTW Biotech Opportunities Ltd reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was USD 4.17 million compared to USD 2.17 million a year ago. Net income was USD 83.19 million compared to net loss of USD 39.44 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.38 USD | 0.00% | +2.22% | -1.60% |
May. 15 | Future Metals celebrates state government grant | AN |
May. 15 | RTW Biotech Opportunities Invests in Lycia Therapeutics $106 Million Funding Round | MT |
1st Jan change | Capi. | |
---|---|---|
-1.60% | 531M | |
+5.69% | 12.91B | |
+10.99% | 9.59B | |
+0.20% | 5.64B | |
+6.16% | 5.38B | |
+6.46% | 5.21B | |
+23.89% | 4.69B | |
+21.05% | 4.53B | |
+2.49% | 4.07B | |
+6.69% | 3.87B |
- Stock Market
- Equities
- RTW Stock
- News RTW Biotech Opportunities Ltd
- RTW Biotech Opportunities Ltd Reports Earnings Results for the Full Year Ended December 31, 2023